MOLN — Molecular Partners AG Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeSmall CapMomentum Trap

Annual balance sheet for Molecular Partners AG, fiscal year end - December 31st, CHF millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Short Term Investments
Cash and Short Term Investments	133	249	187	149	93.1
Net Total Accounts Receivable
Net Total Receivables	25.7	1.7	3.08	2.59	1.91
Prepaid Expenses
Total Other Current Assets
Total Current Assets	164	255	192	154	96.9
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	8.15	7.24	5.68	4.2	5.23
Net Intangible Assets
Total Assets	173	262	198	159	102
Accounts Payable
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	46.9	17.3	14.4	10.8	11
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Funded Status
Total Liabilities	65.4	27.1	21.9	16.9	21.8
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Total Equity	107	235	176	142	80.3
Total Liabilities & Shareholders' Equity	173	262	198	159	102
Total Common Shares Outstanding